The Advisory Board is a means for the directors of CSAW Health to obtain the best available advice from a range of field experts. It is comprised of people who are leaders in their chosen field and have a strong interest in ethical business practices and support the ethos of CSAW Health in terms of our focus on the triple bottom line; returns to shareholders, benefits for the community and support for the environment. Their continued contribution to CSAW Health and the community is essential if we are to continue serving the harm reduction community at the level our clients (end users) deserve.
"The members of the advisory board are not directors of CSAW Health and do not carry any responsibility for financial, Occupational Health & Safety or company liabilities of any kind"
"In terms of the effectiveness of NSPs in preventing hepatitis C infection, it is estimated that between 1988 and 2001, 21,000 hepatitis C infections were prevented across Australia among people who inject. Consequently it is estimated that 16,000 cases of hepatitis C will have been prevented and 90 hepatitis C-related deaths avoided by 2010. "
"Epidemics of HIV among injecting drug users (IDUs) have been prevented, even where there is no decrease in drug use or injecting. Countries which have been most successful in this are countries which have adopted the public health approach known as ‘harm reduction’. Because it is the sharing of contaminated injecting equipment which is responsible for the transmission of HIV among IDUs, decreasing this sharing must be the prime target for prevention efforts. ‘Manual for reducing drug related harm in Asia’ Ed. Nick Crofts (Centre for Harm Reduction, Victoria, Australia)"